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Abstract 16 
Medical grade titanium alloy, Ti-6Al-4V, with TiO2 nanotubes (TiO2-NTs) grown 17 
on the surface and then decorated with silver nanoparticles (Ag NPs) is proposed to 18 
enhance the antimicrobial properties of the bone/dental implants. However, the 19 
decoration with Ag NPs is not consistent and there are concerns about the direct 20 
contact of Ag NPs with human tissue. The aim of this study was to achieve a more 21 
even coverage of Ag NPs on TiO2-NTs and determine their biocidal properties 22 
against Staphylococcus aureus, with and without a top coat of nano hydroxyapatite 23 
(nHA). The decoration with Ag NPs was optimised by adjusting the incubation time 24 
of the TiO2-NTs in a silver ammonia solution, and using biocompatible δ-25 
gluconolactone as a reducing agent. The optimum incubation in silver ammonia 26 
was 7 minutes, and resulted in evenly distributed Ag NPs with an average diameter 27 
of 47.5 ± 1.7 nm attached to the surface of the nanotubes. The addition of nHA did 28 
not compromise the antimicrobial properties of the materials; high resolution 29 
electron microscopy showed S. aureus did not grow on the composite with nHA 30 
and with >80 % biocidal activity measured by the LIVE/DEAD assay, also limited 31 
lactate production. Dialysis experiment confirmed the stability of the coatings, and 32 
showed a slow release of dissolved silver (3.27 ± 0.15 μg/L over 24 h) through the 33 
top coat of nHA. 34 
 35 
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Introduction 46 
Orthopaedic and dental implants should be suitably durable with mechanical properties 47 
that mimic the intended tissue (O'Brien, 2011). The implants must also be biocompatible 48 
and ideally exhibit some antimicrobial properties as infection post-surgery is an 49 
underlying cause of implant failure (Connaughton et al., 2014). The challenge is to make 50 
a medical implant with all these attributes. Titanium dioxide nanotubes (TiO2-NTs) are 51 
readily grown on medical grade titanium whereby they can resist mechanical stresses 52 
similar to those faced by bone (Descamps et al., 2013).  They have also been shown to be 53 
biocompatible with bone cells, partly because they mimic the surface morphology of bone 54 
(Brammer et al., 2012). Crucially the properties of TiO2-NTs can be tuned to the clinical 55 
application by varying the thickness, surface texture and/or decoration of the nanotubes 56 
(Spriano et al., 2018). The relationship between the surface properties of TiO2-NTs and 57 
mechanistic responses of osteoblast cells is also partially understood (Meyerink et al., 58 
2018). However, TiO2-NTs alone are not antimicrobial (Zhao et al., 2011). 59 
Staphylococcus aureus is one of the most common cause of infection in implants 60 
(Rodríguez-Cano et al., 2014). To enhance antimicrobial properties, TiO2-NTs can be 61 
coated with antibiotics such as gentamicin (Yang et al., 2016) or vancomycin (Zhang et 62 
al., 2013). However, infections related to implants are normally caused by a mixture of 63 
microbes (Nie et al., 2017) and individual antibiotics are inevitably only targeted at a few 64 
of the organisms present. There is also the concern of antibiotic resistance (Moriarty et 65 
al., 2016). Alternatively, dissolved metals such as silver, copper and zinc have been 66 
known for their antimicrobial properties for centuries. Their solubility and biological 67 
reactivity have restricted their applications to simple disinfectants in the past, but now 68 
nanoparticulate forms of these metals are available. Of these metals, silver nanoparticles 69 
(Ag NPs, review, Reidy et al., 2013) are arguably the strongest biocide with minimum 70 
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inhibitory concentrations (MIC) for growth of 3.25 mg/l to S. mutans (Besinis et al., 71 
2014a). Ag NPs are also toxic to S. sanguinus when presented as a silver coating on 72 
medical grade titanium alloy (Besinis et al., 2017). However, the rapid release of Ag from 73 
silver-containing coatings may cause toxicity to mammalian cells (Gao et al., 2014), and 74 
instead a controlled release of Ag by enhancing the stability of the coating is desirable 75 
(Zhao et al., 2011).  76 
 It is also possible to decorate Ag NPs onto the surface of TiO2-NTs using 77 
anodization methods (Gunputh et al., 2018), and then add another biocompatible material 78 
to control the Ag release. TiO2-NTs can also be decorated with Ag NPs in the presence 79 
of calcium phosphate NPs (Chernozem et al., 2019), but there are some concerns about 80 
the elastic properties and nanohardness of the implant material when Ca3(PO4)2 is used 81 
(Chernozem et al., 2017). One possible alternative approach is to ‘top-coat’ the silver-82 
containing nanomaterial with a layer of biocompatible hydroxyapatite (HA), so that there 83 
is no hazard to the human tissue and better mechanical properties. Hydroxyapatite (HA) 84 
has a similar structure to bone and is well-known as a biocompatible material that 85 
promotes osteointegration (Ramires et al., 2001, Balani et al., 2007). Nano forms of HA 86 
(nHA) are also available (Ha et al., 2015). Our previous work developed an anti-bacterial 87 
coating consisting of TiO2-NTs grown on Ti-6Al-4V alloy, with clusters of Ag NPs on 88 
the TIO2-NT surface (Gunputh et al., 2018). The aim of the present study was to develop 89 
these coatings further by optimising the incubation time with reducing agents to provide 90 
a more uniform decoration of Ag NPs, and crucially, to determine if antibacterial 91 
properties remained after top coating the materials with nHA. To demonstrate the 92 
antimicrobial properties, the final composite coatings were tested against S. aureus. For 93 
these latter studies, this included counting the proportions of live and dead bacteria on the 94 
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coatings, monitoring microbial activity with a lactate production assay, as well as electron 95 
microscopy to observe coating integrity and the presence of any microbes. 96 
Materials and Method 97 
Titanium dioxide nanotubes (TiO2-NTs) were self-assembled on the surface of Ti-6Al-98 
4V alloy discs followed by the chemical reduction of silver to form Ag NPs on the 99 
nanotubes. For some of the silver coated nanotubes, nHA was sintered to the composite 100 
coating. After characterising the different coatings formed, the antibacterial properties of 101 
all of them were tested in the presence of S. aureus.  102 
Growth of TiO2-NTs with Ag NPs and HA coating 103 
The synthesis of the composite coatings started with TiO2-NTs followed by the addition 104 
of Ag NPs and last nHA. To start with, the self-assembly of the TiO2-NTs on to titanium 105 
alloy discs was conducted using an anodisation process as previously optimised 106 
(Danookdharree et al., 2015). Briefly, this was a 1 hour electrochemical reaction in a 107 
mixture of 1 mol/L NH4HPO4 and 0.5 wt% NH4F (0.5 g of NH4F in 100 mL of ammonia 108 
solution) at 20 V. All the coated discs were then annealed at 350 ºC for 2 h in a furnace 109 
to achieve the anatase phase (Carbolite RWF 1200, Carbolite Engineering Services, Hope 110 
Valley, UK). The TiO2-NTs were then functionalised by treating them with 2 mol/L 111 
NaOH at 50 ºC for 2 minutes (Parcharoen et al., 2014). This resulted in the formation of 112 
sodium titanate (Na2Ti3O7) which is a reactive surface for the next steps in the synthesis 113 
of the composite material. 114 
Silver nanoparticles were then chemically reduced on the surface of the TiO2-NTs 115 
as previously described (Gunputh et al., 2018). Briefly, a silver ammonia solution was 116 
prepared, at room temperature and with continuous stirring, by mixing 2.545 g of silver 117 
nitrate and 900 mL of ultrapure water, followed by 15 mL of 1 M NaOH.  A precipitate 118 
6 
 
of silver oxide formed, but was continuously mixed to remain in suspension. 119 
Concentrated liquid ammonia (13.4 M; density, 0.910 kg/m3) was then added dropwise 120 
to the mixture until all the oxide had dissolved. Pure water was then added to bring the 121 
final volume to 1000 mL. The resulting solution of silver ammonia, [Ag(NH3)2]+, (15 122 
mM) was allowed to stir for a further 10 minutes to ensure complete reaction and mixing. 123 
Afterwards, 2 mM δ-gluconolactone solution (Sigma Aldrich, UK) was prepared in 12 124 
mM NaOH, the volume of which was dependent on the experiment performed. 125 
The titanium alloy discs covered with TiO2-NTs were immersed in silver ammonia 126 
first, allowing the cationic silver ammonia to attach to –O- residues of the nanotubes 127 
(Gunputh et al., 2018). After an initial exposure to the silver ammonia, the samples were 128 
ultrasonicated in deionised water at 12 MHz for 5 minutes to remove any loosely attached 129 
silver ammonia; after which the disks were air dried at room temperature. The samples 130 
were then exposed to the gluconolactone solution for 5 minutes. Depending on the 131 
exposure time to silver ammonia, the samples were identified as TiO2-Ag3, TiO2-Ag7 132 
and TiO2-Ag10 for an exposure of 3, 7 and 10 minutes in silver ammonia respectively, 133 
and all treated for 5 minutes in gluconolactone solution (n = 3 each). Gluconolactone was 134 
expected to reduce the silver ammonia to Ag NPs which are attached on the surface of 135 
the TiO2-NTs. The samples were again ultrasonicated in deionised water for 5 minutes 136 
with the aim of removing the loosely attached Ag NPs.  137 
After the optimisation of the incubation time for the synthesis of Ag NPs on the 138 
TiO2-NT discs, hydroxyapatite was finally added using a sintering method (Besinis et al., 139 
2017).  Briefly, 7 minutes was deemed the optimum time for the silver ammonia 140 
treatment, and so TiO2-Ag7 discs were placed in 24-well plates and sterilised with 70 % 141 
ethanol (n = 12 discs). Afterwards, 20 µL of 10 wt% nHA solution (Sigma Aldrich, UK) 142 
was evenly pipetted on top of the discs after which they were left to dry at room 143 
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temperature for 48 hours. Subsequently, the discs were placed in a porcelain dish and 144 
gradually heated (Carbolite furnace, Hope, UK) at 10 °C per min to 500 °C. The final 145 
temperature was maintained for 10 minutes after which the temperature was gradually 146 
reduced to room temperature. The 500 °C temperature was chosen as it was high enough 147 
to cause sintering, while being below the melting point of silver. The change in 148 
temperature was gradual to ensure maintaining the crystallinity of the nHA. The resulting 149 
discs are hereafter termed ‘TiO2-Ag7-HA’.  150 
 151 
Characterisation of the coatings 152 
The morphology and chemical composition of the TiO2 at each step of the synthesis (i.e., 153 
addition of Ag-NPs and then HA) was analysed by scanning electron microscopy with 154 
energy dispersive spectroscopy (SEM/EDS). Figure 1 shows the surface morphology 155 
prior to the HA additions and for different incubations times with silver ammonia.  The 156 
growth of the TiO2-NTs gave generally good coverage of the alloy, as expected 157 
(Danookdharree et al., 2015). When 3 minutes incubation time was used (TiO2-Ag3), the 158 
TiO2-NTs had less spherical Ag NPs on the surface (Figure 1B). The samples incubated 159 
for 7 minutes (TiO2-Ag7) had a more uniform distribution of Ag NPs. In both TiO2-Ag3 160 
and TiO2-Ag7, the nanotubular characteristic of the TiO2 was still visible after the growth 161 
of Ag NPs. However in TiO2-Ag10, the Ag NPs grown covered the whole surface of the 162 
TiO2 with some clustering observed (Figure 1D). The EDS analysis of the white spherical 163 
nanoparticles on the discs confirmed the presence of silver with the weight percentage of 164 
the latter over the coating increasing from TiO2-Ag3 to TiO2-Ag10 (5-8 wt%) to the 165 
contrary of Ti, Al and O which were found to be decreasing. The incubation time also 166 
affected the primary size of the Ag NPs, as observed by electron microscopy, with 167 
diameters of 88.25 ± 5.1, 47.5 ± 1.7, 30 ± 2.4 nm  for incubations of 3, 7 and 10 minutes 168 
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with silver ammonia, respectively (all significantly different from each other, ANOVA, 169 
P < 0.05). 170 
For the logistics of biological testing, one ‘best’ composite had to be selected for 171 
experimental work. After considering all the characterisation information, TiO2-Ag7 was 172 
chosen as the coated samples to be taken forward for further testing. This was selected on 173 
the basis that it had the most uniform coating with almost no clustering of and full surface 174 
coverage of the Ag NPs (Figure 2). After the addition of nHA to the latter coating, another 175 
uniformly distributed coating was obtained (Figure 2B). The EDS analysis (Figure 2D) 176 
confirms the presence of Ca and P as part of the nHA. As expected, the amount of silver 177 
now detected with the HA surface was less than TiO2-Ag7 alone (< 5 wt %).  Some 178 
cracking of the nHA layer was observed (Figure 2D), but this regarded as a desirable 179 
feature to facilitate the slow release of the underlying silver. 180 
 181 
Dialysis experiment and the release of dissolved metal  182 
A dialysis experiment was conducted according to Besinis et al (2014b) using the TiO2-183 
Ag7 and TiO2-Ag7-HA discs to inform on the release of any dissolved Ag with respect 184 
to antibacterial properties, and on the stability of the coatings (Besinis et al., 2014a). A 185 
simulated body fluid (SBF) was used for these experiments (in mmol/l):  Na+, 142; K+, 186 
5.0; Mg2+, 1.5; Ca2+, 2.5; Cl-, 147.8; HCO3-, 4.2; HPO42-, 1.0; SO42-, 0.5 (Kokubo et al., 187 
1990), with the pH adjusted to 7.2 with a few drops of 1 mol/L HCl. Experiments were 188 
conducted in triplicate at room temperature in previously acid washed (5% nitric acid) 189 
and deionised glassware. Dialysis tubing (MW cut off, 12 000 Da, Sigma Aldrich, UK), 190 
was cut in 7 cm x 2.5 cm lengths and sealed at one end using a Mediclip; then filled with 191 
one Ti alloy discs as appropriate with 7 mL of SBF. The dialysis bag was closed with 192 
another Mediclip and then suspended in a 500 mL pyrex glass beaker containing 243 mL 193 
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of SBF (i.e., total volume 250 mL). The beakers were gently stirred throughout, and 4 194 
mL aliquots of the SBF were collected from the external compartment of the beaker at 0, 195 
0.5, 1, 2, 3, 4, 6, 8, 24 h. The SBF samples were acidified with a drop of 70 wt% nitric 196 
acid and stored for metal analysis (see below). At the end of the 24 h, the dialysis bags 197 
were also carefully opened and 4 ml of the fluid therein collected for metal analysis. 198 
Dialysis curves were plotted using SigmaPlot 13.0 (Systat Software, Inc.), after deducting 199 
the background ionic concentrations of the SBF. A first order rectangular hyperbola 200 
function was used to fit dialysis curves to the raw data. The maximum initial slope of the 201 
curves informed on the maximum apparent dissolution rate of each substance. 202 
 203 
Plate preparation and exposure to S. aureus 204 
The experimental design involved exposing S. aureus to the coated samples of TiO2-Ag7 205 
and TiO2-Ag7-HA in 24-well, flat-bottom sterile polystyrene plates (Thermo Fischer 206 
Scientific, Loughborough, UK). TiO2-NT coated discs were used as a control for the 207 
composite coating effect. Silver nitrate was used as a metal salt control for any possible 208 
dissolved silver effect from the coating. Silver nanoparticles alone were also used as a 209 
control for Ag NP effect that might arise from the coatings. S. aureus was allowed to 210 
grow on its own as a negative control. Nine replicate runs were conducted for each type 211 
of coated samples and the controls (n = 6 for biochemical assays and n = 3 for SEM). 212 
Following the approach by Besinis et al (2014a), the materials were exposed to S. aureus 213 
for 24 h and the proportion of live to dead cells and the amount of lactate produced were 214 
evaluated (see biochemical assays below). The concentration of total dissolved silver, 215 
calcium and phosphorus released from the coating in the SBF were also measured.  216 
S. aureus was chosen as it is considered to be one of the main causes of infection 217 
in orthopaedic and dental implants (Swank and Dragoo, 2013, Tsikandylakis et al., 2014). 218 
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S. aureus was cultured in brain heart infusion (BHI) broth (Lab M Ltd, Bury, UK) at 37 219 
ºC. A bacterial suspension having optical density 0.018 at 595 nm absorbance 220 
(Spectrophotometer Genesys 20, Fisher Scientific, Loughorough, UK) was prepared in 221 
the BHI broth at a concentration of 1 × 107 cells/mL.  For the experiments, 2 mL of the 222 
bacterial culture was pipetted in each well of a 24-well plate containing TiO2-NTs, TiO2-223 
Ag7, TiO2-Ag7-HA, AgNO3 (0.001M), or Ag NPs (107.9 mg/L equal to 0.001M) 224 
dispersed in ultrapure deionised water on their own (n = 9 replicates of each). A silver 225 
concentration of 0.001M was used for the positive controls as it was found that 0.001M 226 
was the maximum amount of silver released from the coatings. The 24-well microplates 227 
were then incubated at 37 ºC on a shaking table. At the end of the overnight exposure, six 228 
of the replicate plates were used for biochemistry. An aliquot (1 mL) of the exposed broth 229 
from each well were collected for the LIVE/DEAD® kit and lactate production assays 230 
(see below). The remaining broth was acidified with 70 wt% HNO3 and used for metal 231 
determination. Then the remaining adherent bacterial were collected. Bacterial pellets 232 
were obtained whereby the samples from the wells were sonicated (12 MHz) for 60 s in 233 
2 mL of sterile saline to remove the bacteria from the discs (Besinis et al., 2014b). Then, 234 
1 mL of the resulting suspension were allowed to grow in 5 mL of BHI broth for 5 h at 235 
37 ºC on a shaking table with the aim of  increasing the amount of live cells in order to 236 
readily measure them with the Live/Dead assay. The viability of the cells and the amount 237 
of lactate in the suspension was also assessed, followed by the measurement of the ionic 238 
composition of the latter. For the remaining three replicates, the broth was removed and 239 
the samples were prepared for electron microscopy.   240 
 241 
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Cell viability and lactate production assays 242 
The cell viability of S. aureus in both the exposed broth and incubated cell suspension 243 
from all of the relevant treatments and controls [TiO2-NTs, TiO2-Ag7, TiO2-Ag7-HA, 244 
AgNO3 (0.001M), and Ag NPs] were assessed using the L7012 LIVE/DEAD® 245 
BacklightTM Kit (Invitrogen Ltd, Paisley, UK), exactly according to Gunputh et al. 246 
(2018). Briefly, 100 μL of the exposed broth and 100 μL of the incubated homogenate 247 
from each replicate was subject to several washes with sterile NaCl solution. Then 100 248 
μL of the final suspension from each well were used for fluorimetry in clean 96 well 249 
plates with 100 μL of freshly prepared dyes from the LIVE/DEAD kit. Microplate were 250 
incubated in the dark at room temperature for 15 min and the fluorescence measured on 251 
a Cytofluor II fluorescence plate reader (excitation, 485 nm; emission at 530 nm and 645 252 
nm). The readings at 530 nm were divided by the readings at 645 nm in order to obtain 253 
the percentage of live to dead cells in the exposed broth and the incubated cell suspension 254 
from the different samples and controls according to the kit instructions. 255 
The metabolic activity of S. aureus was assessed by measuring the amount of lactate 256 
present in both the exposed broth and incubated cell suspension from the wells containing 257 
TiO2-NTs, TiO2-Ag7, TiO2-Ag7-HA, AgNO3 (0.001M), and Ag NP (6 replicates of each) 258 
according to Besinis et al (2013). Briefly, 100 μL of the exposed broth, or 100 μL of the 259 
incubated homogenate as appropriate, were transferred to a V-bottom 96-well microplate 260 
and were centrifuged at 2000 rpm for 10 minutes to generate a clean supernatant that 261 
could be measured for total lactate. Then, in a new plate, 1 μL of 1000 units/mL of lactate 262 
dehydrogenase (Sigma-Aldrich Ltd, UK) was pipetted into wells of a 96-well plate 263 
followed by 10 μL of 40 mmol/L nicotinamide adenine dinucleotide and 200 μL of 0.4 264 
mol/L hydrazine prepared in a glycine buffer of pH 9. Ten μL of the supernatants were 265 
then added, mixed and incubator at 37ºC for 2 hours to allow lactate production to occur. 266 
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The absorbance was then read at 340 nm against lactic acid as standards (0, 0.25, 0.5, 1.0, 267 
2.0, 4.0, 8.0 mmol/L).  268 
 269 
Metal analysis following S. aureus exposure 270 
The exposed broth and the detached bacteria were analysed for silver, calcium and 271 
phosphorus composition. After the exposure to S. aureus, 1 mL of the broth or the 272 
detached bacteria were diluted with Milli-Q water to a final volume of 5 mL and acidified 273 
(few drops of 70 wt% nitric acid). Total Ag concentrations were determined by 274 
inductively coupled plasma mass spectrometry (ICP-MS, Varian 725-ES Melbourne, 275 
Australia), and total Ca or P by optical emission spectrometry (ICP-OES, Thermo 276 
Scientific XSeries 2, Hemel Hempstead, UK). Calibrations for both instruments were 277 
performed with matrix-matched analytical grade standards. For ICP-MS the standards 278 
and samples contained internal references (0.5, 0.25 and 1% of iridium) for SBF, broth 279 
and any homogenates made from bacteria. In the complex matrix of broth and SBF, the 280 
detection limit was around 0.001 µg/L for Ag by ICP-MS, and 5 µg/L for Ca and 40 µg/L 281 
for P by ICP-OES. 282 
 283 
Imaging of the attached S. aureus 284 
The remaining 3 repeats of the control, TiO2, TiO2-Ag7, TiO2-Ag7-HA, AgNO3 and Ag 285 
NP were examined by scanning electron microscope to confirm the presence of S. aureus 286 
on the different surfaces. After the 24 h exposure to S. aureus, the supernatants were 287 
removed and the plates carefully washed twice with sterile saline (0.85 wt% NaCl). Then 288 
2 mL of 3 wt% glutaraldehyde in 0.1 mol/L cacodylate buffer was added to each well and 289 
was allowed to stay overnight at 4 ºC. The next day, the glutaraldehyde was removed and 290 
the samples were washed with 0.1 mol/L cacodylate buffer. Specimens were serially 291 
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dehydrated through ethanol solutions, coated with carbon, and viewed under a 292 
JEOL7001F SEM. Each specimen was viewed at three different random locations (i.e., 3 293 
images of each specimen x 3 replicate samples). Care was taken to systematically 294 
photograph the specimens without bias and at the same magnifications for all treatments. 295 
 296 
Statistical analysis 297 
The data from the cell viability assay, the lactate production assay and the ionic 298 
concentration measurements were analysed using Statgraphics Centurion XVII (StatPoint 299 
Technologies, Inc.). After descriptive statistics, data were checked for normality and for 300 
equal variances (Levene’s test). When data were parametric, the data was analysed for 301 
treatment or time effects using one way ANOVA with Fisher’s LSD test post-hoc. In 302 
cases of unequal variances, the data were transformed before analysis and where the data 303 
remained non-parametric, the Kruskal Wallis test was used. Data are presented as mean 304 
± S.E.M unless otherwise stated. The default 95% confidence level was used for all 305 
statistics. 306 
Results  307 
Dialysis experiment and the stability of coatings  308 
Figure 3 shows the results of the dialysis experiments. The total concentration of silver 309 
from the samples without any silver coatings was minimal as expected. In the presence 310 
of Ag-containing materials, there was a rise in the total Ag concentration in the external 311 
compartment of the dialysis bag, reaching a maximum of 5.44 ± 0.06 and 3.27 ± 0.15 312 
μg/L from TiO2-Ag7 and TiO2-Ag7-HA respectively. The maximum dissolution rates 313 
were 0.17 ± 0.01 μg/h   and 0.21 ± 0.05 μg/h for Ag from TiO2-Ag7 and TiO2-Ag7-HA 314 
respectively (statistically different, ANOVA, p<0.05, n = 3). Figure 3 also shows the 315 
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dissolution of calcium and phosphorus from the coated samples. A similar trend in the 316 
total concentration was observed for both Ca and P in the beaker (Figure 3B and 3C). The 317 
maximum concentration of Ca reached was 86.5 ± 1.48 and 92.0 ± 0.36 mg/L from TiO2-318 
Ag7 and TiO2-Ag7-HA respectively with a maximum dissolution rate of 68.8 ± 1.92 mg/h 319 
and 73.4 ± 0.07 mg/h respectively. The maximum concentration of P reached was 27.6 ± 320 
0.73 and 28.4 ± 0.24 mg/L from TiO2-Ag7 and TiO2-Ag7-HA respectively with a 321 
maximum dissolution rate of 21.8 ± 0.42 and 23.0 ± 0.51 mg/h respectively. 322 
Confirming silver exposure in the broth during S. aureus exposures 323 
The measured total Ag concentrations in the broth during the exposure of S. aureus to the 324 
different composite coating and relevant controls are shown in Figure 4A. For the controls 325 
and materials without silver, as expected they showed only a background concentration 326 
of the metal (6.78 μg/L). The positive controls of AgNO3 and Ag NPs alone had a high 327 
concentration of silver, 67.7 ± 2.1 and 1.36 ± 0.025 mg/L respectively. Where the coatings 328 
contained Ag NPs, total Ag (form unknown) was readily measured in the broth (Figure 329 
4A). The broth exposed to both TiO2-Ag7 and TiO2-Ag7–HA discs had 2.08 ± 0.2 and 330 
0.50 ± 0.1 mg/L of total Ag respectively (significantly less total Ag from TiO2-Ag7–HA 331 
(Kruskal-Wallis, p <0.05; n = 6). Thus the coating with HA impeded the release of the 332 
majority of the silver from the coatings in the presence of the broth. 333 
 334 
Cell morphology and survival 335 
Specimens from the controls and treatments were examined for abundance and 336 
morphology of the bacteria by electron microscopy at the end of the experiment (Figure 337 
5). As expected the bacteria cultured directly on the plastic wells (control) survived and 338 
grew on the whole surface (Figure 5A). The bacteria also grew on the TiO2-NTs (Figure 339 
5B), but were sparse or absent on all the Ag-containing materials (Figures 5C-F). The 340 
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electron microscopy observations were consistent with by the proportions of live bacteria 341 
detected using the L7012 LIVE/DEAD® BacklightTM Kit after a 24 h of exposure to the 342 
composite materials or the controls (Figure 6). The percentage of live bacteria was high 343 
in the broth (72.5 ± 2.9%) and on the surface of the plastic well (100.9 ± 2.6%), as 344 
expected. The control cells were the most metabolically active compared to all other 345 
treatments (Kruskal Wallis, p < 0.05, n = 6) as confirmed by the lactate production assay 346 
(Figures 6C-D).  347 
Slightly few bacteria grew on the TiO2-NTs, but with >80% alive on the surface 348 
this material was not biocidal. In contrast, the bacteria exposed to silver controls (AgNO3 349 
or dispersions of Ag NP) were dead (< 1% live bacteria) and with negligible lactate 350 
production (0.2 mM or much less, Figure 6). AgNO3 and Ag NPs were equally effective 351 
biocides (not statistically different from each other, Figure 6). Both TiO2-Ag7 and TiO2-352 
Ag7–HA coatings had a significantly lower percentage of live to dead cells (6.74 ± 0.98% 353 
and 1.78 ± 0.29% respectively) as compared to the control or TiO2-NTs. The TiO2-Ag7 354 
was as effective as AgNO3 or dispersions of Ag NPs at killing bacteria with only 3.4 ± 355 
0.3% live on the former and negligible lactate production (Figures 6A and C). Notably, 356 
with the addition of nHA, the TiO2-Ag7–HA coating still retained most of its biocidal 357 
properties with 13.9 ± 1.0% of live cells attached to its surface and only 1.07 ± 0.03 mM 358 
of lactate production (Figures 6A and C). 359 
Discussion 360 
Improved fabrication and Ag release from the composite coating 361 
In this study, TiO2-NTs were successfully decorated with a uniform distribution of 362 
individual Ag NPs on the surface (Figure 1C). This is a marked improvement on our 363 
previous attempts to reduce silver ions to Ag NPs on the surface of TiO2-NTs using the 364 
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biocompatible reducing agent, δ-gluconolactone (Gunputh et al., 2018), where the 365 
distribution of the nanoparticles was not uniform and showed micron and nano-sized 366 
clusters of the particles. Furthermore, in the present study the as formed TiO2-NTs were 367 
initially treated at 350 ̊C to increase their chemical stability (Zazpe et al., 2017) followed 368 
by an alkaline treatment in 2 mol/L NaOH which made the nanotube more receptive to 369 
silver ammonia solution.  When the TiO2-NTs react with NaOH, sodium titanate crystals 370 
are formed on the nanotubes (Tsai and Teng, 2006) as per Equation (1):  371 
2TiO2 +  2NaOH  Na2Ti2O5.H2O       (1) 372 
When exposed to silver ammonia solution, the Na+ is substitued by the silver ammonia 373 
complex as per Equation (2) (Gunputh et al., 2018). 374 
Na2Ti2O5.H2O  + 2[Ag(NH3)2]+  [Ag(NH3)2]2 - Ti2O5.H2O   (2) 375 
The latter attachment of the silver ammonia to titanate is stronger than the bond in the 376 
TiO2-[Ag(NH3)2]+ complex (Gunputh et al., 2018). Hence, the exposure to δ-377 
gluconolatone reduced the silver comples to silver nanoparticles still attached to the 378 
nanotubes as per Equations (3) below.  379 
 380 
 381 
                                                                    382 
                                    383 
In the presence of δ-gluconolactone, the silver ammonia, while still being attached to the 384 
nanotubes, is reduced to Ag NPs. Hence, the decoration is achieved, and by modifying 385 
 (3) 
+ [Ag(NH3)2]2 Ti2O5.H2O    
 + 2Ag0 TiO2 + 2H2O + 4NH3 + H+   
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the incubation time the clustering and size of the Ag NPs can be controlled (Gunputh et 386 
al., 2018). In the present study this was optimised, with the TiO2-Ag7, achieving the 387 
desired decoration (Figure 1C). Further details on the stability of the TiO2-NTs such as 388 
the current density, porosity, pH effects, and Gibbs free energy can be found elsewhere 389 
(Danookdharree et al., 2015). The absence of high Ag concentrations in the broth at the 390 
end of the experiment also suggests the TiO2-NTs with their Ag NP decoration was 391 
remaining attached to the Ti alloy. The visible presence of Ag NPs on the materials 392 
(Figure 1) argues that the Ag is remaining in the reduced form, Ag0, as expected from x-393 
ray photoelectron spectroscopy (XPS) studies of Ag NPs grown on TiO2 materials 394 
(Kamaraj et al., 2015). Also, the low µg/L releases of Ag by dissolution, suggests very 395 
little of the Ag is oxidising (i.e., as assumed soluble Ag+), and in any event it will 396 
spontaneously form sparingly soluble AgCl complexes in the media (Besinis et al., 397 
2014a), not silver oxides. 398 
For biocidal properties, it is desirable to have a slow release of Ag from the surface 399 
of the material. This was achieved with the Ag NPs alone decorated on TiO2-NTs, 400 
releasing µg/L amounts of total Ag into the surrounding biological media (Figures 3 and 401 
4). However, the osteoblasts critical to the healing of bone show toxicity and lose around 402 
75% of their vital alkaline phosphatase activity when in direct contact with Ag NPs on 403 
TiO2-NTs (Zhao et al., 2011). So, our approach was to include a top coat of nHA, which 404 
still allowed some release of dissolved Ag in dialysis experiments with SBF (Figure 3) 405 
and into the broth during exposure to S. aureus (Figure 4). 406 
   407 
Antibacterial properties 408 
In the present study, as expected, the TiO2-Ag7 coating was biocidal with almost no live 409 
bacteria attached to the surface or remaining suspended in the broth (Figures 5 and 6). 410 
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Indeed, the TiO2-Ag7 coating was as potent as AgNO3 solution or dispersions of free Ag 411 
NPs (Figures 5 and 6). The biocidal properties in this circumstance could arise either from 412 
direct contact toxicity of the Ag NPs on the cell walls of the bacteria, or from any 413 
dissolved Ag released (Reidy et al., 2013).  It is also theoretically possible for UV light 414 
stimulation to catalyse the oxidation of some Ag0 with TiO2 to form reactive oxygen 415 
species that subsequently kill bacteria (Hajjaji et al., 2018), although this is not relevant 416 
to the conditions here. Regardless of mechanisms, there are few reports of the MIC values 417 
for Ag NPs suspensions with S. aureus. Yuan et al. (2017) reported an MIC of 2 µg/mL 418 
for a multi-drug resistant stain of S. aureus. Similarly for methicillin-resistant S. aureus 419 
(MRSA), Paredes et al. (2014) reported MIC values of around 0.25 µg/mL for Ag NPs. 420 
Although neither of these latter studies included silver salt controls or particle dissolution 421 
measurements, it suggests that low mg/L concentrations of Ag NPs are biocidal, as 422 
observed here (Figures 5 and 6). Dissolved silver is arguably more toxic and as little as 423 
50 µg/L can completely kill S. aureus in 24 h in physiological saline (Jung et al., 2008). 424 
In the present study, dissolution of 2-3 µg/L of dissolved Ag was demonstrated in the 425 
dialysis experiments with TiO2-Ag7 (Figure 3), and this material showed no appreciable 426 
microbial biofilm (Figure 5). This magnitude of apparent dissolved Ag release is also far 427 
below the acute toxicity values for mammalian cells. For example, fibroblasts have an 428 
EC50 of 1.7 mg/L for AgNO3 and between 17-35 mg/L for Ag NPs depending on particle 429 
size (Ivask et al., 2014). Bone cement loaded with up to 1% w/v as Ag NPs also has no 430 
appreciable toxicity to osteoblasts in vitro (Alt et al., 2004). Thus the silver release is 431 
biocidal, but not likely to be toxic to the surrounding human tissue. 432 
The presence of a nHA top coat did not hinder the antibacterial properties of the 433 
implant material (Figure 5). The nHA formed a consistent layer over the TiO2-NTs 434 
decorated with Ag NPs, but with some cracks in the nHA surface (Figure 2). This has 435 
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been observed before with nHA coatings and is likely due to differences in the thermal 436 
expansion coefficients of nHA compared to the underlying materials (Besinis et al., 437 
2017). The small fissures in the nHA coat serve to enable the controlled release of the 438 
underlying silver (e.g., from electroplated titanium alloy, (Besinis et al., 2017) and a 439 
similar observation was made here with the TiO2-Ag7-HA treatment (Figures 3 and 4). 440 
Thus overall, the fissures in the nHA top coating are a desirable feature that enable the 441 
leaching of some Ag to cause antimicrobial properties towards S. aureus, and yet the nHA 442 
would also provide a known biocompatible surface for human osteoblasts. 443 
In conclusion, the chemical reduction of silver ammonia using δ-gluconolactone 444 
was successfully used to synthesise individual Ag NPs that consistently decorated the 445 
surface of TiO2-NTs. Both TiO2-Ag7 and TiO2-Ag7-HA exhibited antibacterial 446 
properties, but the latter material with a nHA top coat is more desirable from the 447 
viewpoint of biocompatibility with human cells. The next step in the research will be to 448 
explore the adherence and differentiation of osteoblasts on the TiO2-Ag7-HA with a view 449 
to demonstrating osseointegration of the implant material with human bone.  450 
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Figure 1: SEM images of Ti-6Al-4V discs coated with (A) TiO2 nanotubes (×50 000), 595 
(B) TiO2-Ag3 (×30 000), (C) TiO2-Ag7 (×30 000), (D) TiO2-Ag10 (×30 000) for 596 
incubations of 3, 7 and 10 minutes in silver ammonia solution respectively. The respective 597 
EDS analysis are of the Ag NPs formed on the surface represented by white spheres/dots 598 
in the images (example images from n = 3 preparations).  599 
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Figure 2: SEM images of (A) TiO2-Ag7 (×5000) and (B) TiO2-Ag7-HA (×200) at low 
magnifications to show coverage of the surface, and their magnified versions in (C, ×30 
000) and (D, ×1000) respectively with EDS spectra confirming the expected elemental 
composition (example images from n = 3 preparations).  
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Figure 3: Concentration of (A) total dissolved silver, (B) calcium, and (C) phosphorus 670 
measured in simulated body fluid following dialysis of a well without any disc,  titanium 671 
alloy discs coated with TiO2 (TiO2-NTs), TiO2-Ag7 (TiO2-NTs decorated with Ag NPs), 672 
and  TiO2-Ag7-HA (TiO2-NTs decorated with Ag NPs, and then a coating of nano 673 
hydroxyapatite). Dialysis experiments were performed in triplicate and a rectangular 674 
hyperbola function was fitted to the raw data points using Sigmaplot. 675 
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Figure 4: Concentration of (A) total silver, (B) calcium, and (C) phosphorus in the exposed broth after overnight growth of S. aureus on: Blank 692 
(control with no Ti alloy disc, cells grown directly on the plastic culture plate), TiO2 (TiO2-NTs), TiO2-Ag7 (TiO2-NTs decorated with Ag NPs), 693 
and TiO2-Ag7-HA (TiO2-NTs decorated with Ag NPs, and then a coating of nano hydroxyapatite). AgNO3 and Ag NPs are silver controls, where 694 
the bacteria were grown in broth with silver nitrate solution or a dispersion of Ag NPs (i.e., not as a coating). Values are means ± SEM, n = 6 695 
replicates. Different letters indicate a statistically significant difference between treatments (P < 0.05, Kruskal-Wallis). 696 
30 
 
 697 
  
  
  
Figure 5: SEM images of attached S. aureus (white spherical structures as shown by 
arrows) after overnight culture in 24-well microplates: (A) Blank (control with no Ti 
alloy disc, cells grown directly on the plastic culture plate), (B) Ti alloy with TiO2 
nanotubes on the surface (TiO2-NTs), (C) AgNO3 solution, (D) Ag NPs in 
suspension, (E) TiO2-NTs decorated with Ag NPs (TiO2-Ag7), and (F) TiO2-NTs 
decorated with Ag NPs, and then a coating of nano hydroxyapatite (TiO2-Ag7-HA). 
Note, the AgNO3 and Ag NPs in suspension are silver controls, where the bacteria 
were grown with the substances added to the broth (i.e., not as a coating).  
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 700 
Figure 6: The proportion of live to dead S. aureus (panels A and B) and lactate production 701 
(panels C and D) by the organism after 24 h when attached to the surface of the materials 702 
(left hand panels), or remaining suspended in the broth (right hand panels). Blank (control 703 
with no Ti alloy disc, cells grown directly on the plastic culture plate), TiO2 (TiO2-NTs), 704 
TiO2-Ag7 (TiO2-NTs decorated with Ag NPs), and TiO2-Ag7-HA (TiO2-NTs decorated 705 
with Ag NPs, and then a coating of nano hydroxyapatite). AgNO3 and Ag NPs are silver 706 
controls, where the bacteria were grown in broth with silver nitrate solution or a 707 
dispersion of Ag NPs (i.e., not as a coating). Values are means ± SEM, n = 6 replicates. 708 
Different letters indicate a statistically significant difference between treatments (P < 709 
0.05, Kruskal-Wallis). 710 
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